| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer
|
Chung, Sui Chu
|
|
2009
|
45 |
Supplement 1 |
p. 174-182
9 p.
|
artikel
|
| 2 |
An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer
|
Caponigro, F.
|
|
2009
|
45 |
Supplement 1 |
p. 48-55
8 p.
|
artikel
|
| 3 |
Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor
|
Kong, Dexin
|
|
2009
|
45 |
Supplement 1 |
p. 857-865
9 p.
|
artikel
|
| 4 |
A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: A study of the National Cancer Institute of Canada Clinical Trials Group
|
Goss, Glenwood
|
|
2009
|
45 |
Supplement 1 |
p. 782-788
7 p.
|
artikel
|
| 5 |
A phase I and pharmacokinetic study of gemcitabine given by 24-h hepatic arterial infusion
|
van Riel, J.M.
|
|
2009
|
45 |
Supplement 1 |
p. 2519-2527
9 p.
|
artikel
|
| 6 |
A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer
|
Vergote, Ignace
|
|
2009
|
45 |
Supplement 1 |
p. 1415-1423
9 p.
|
artikel
|
| 7 |
A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned?
|
Koopman, Miriam
|
|
2009
|
45 |
Supplement 1 |
p. 1935-1949
15 p.
|
artikel
|
| 8 |
Calendar
|
|
|
2009
|
45 |
Supplement 1 |
p. I-IV
nvt p.
|
artikel
|
| 9 |
Capecitabine and vinorelbine in metastatic breast cancer
|
Chan, Arlene
|
|
2009
|
45 |
Supplement 1 |
p. 2253-2265
13 p.
|
artikel
|
| 10 |
β-Carotene promotes the development of NNK-induced small airway-derived lung adenocarcinoma
|
Al-Wadei, Hussein A.N.
|
|
2009
|
45 |
Supplement 1 |
p. 1257-1264
|
artikel
|
| 11 |
Characterisation of gene expression profiles of yeast cells expressing BRCA1 missense variants
|
Di Cecco, Leontina
|
|
2009
|
45 |
Supplement 1 |
p. 2187-2196
10 p.
|
artikel
|
| 12 |
Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure
|
George, S.
|
|
2009
|
45 |
Supplement 1 |
p. 1959-1968
10 p.
|
artikel
|
| 13 |
Clinical relevance of the triple-negative breast cancer concept: Genetic basis and clinical utility of the concept
|
Linn, Sabine C.
|
|
2009
|
45 |
Supplement 1 |
p. 11-26
16 p.
|
artikel
|
| 14 |
Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer
|
Dauplat, J.
|
|
2009
|
45 |
Supplement 1 |
p. 2977-2983
7 p.
|
artikel
|
| 15 |
Correcting population-based survival for DCOs – Why a simple method works and when to avoid it
|
Silcocks, Paul
|
|
2009
|
45 |
Supplement 1 |
p. 3298-3302
5 p.
|
artikel
|
| 16 |
CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma
|
Stocker, Gertraud
|
|
2009
|
45 |
Supplement 1 |
p. 3326-3335
10 p.
|
artikel
|
| 17 |
Developing a CTCAEs patient questionnaire for late toxicity after head and neck radiotherapy
|
Ho, K.F.
|
|
2009
|
45 |
Supplement 1 |
p. 1992-1998
7 p.
|
artikel
|
| 18 |
Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1α involvement in CYP3A4 repression
|
Legendre, Claire
|
|
2009
|
45 |
Supplement 1 |
p. 2882-2892
11 p.
|
artikel
|
| 19 |
Duration of symptoms, stage at diagnosis and relative survival in colon and rectal cancer
|
Jullumstrø, Eivind
|
|
2009
|
45 |
Supplement 1 |
p. 2383-2390
8 p.
|
artikel
|
| 20 |
ECCO – the European CanCer Organisation Full Members
|
|
|
2009
|
45 |
Supplement 1 |
p. xvii-xxi
nvt p.
|
artikel
|
| 21 |
Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil
|
Ravizza, Raffaella
|
|
2009
|
45 |
Supplement 1 |
p. 890-898
9 p.
|
artikel
|
| 22 |
EJC NEWS ISSUE 1, 2009
|
|
|
2009
|
45 |
Supplement 1 |
p. 1-5
5 p.
|
artikel
|
| 23 |
Endo180 expression with cofunctional partners MT1-MMP and uPAR–uPA is correlated with prostate cancer progression
|
Kogianni, Giolanta
|
|
2009
|
45 |
Supplement 1 |
p. 685-693
9 p.
|
artikel
|
| 24 |
EORTC-GU group expert opinion on metastatic renal cell cancer
|
de Reijke, Theo M.
|
|
2009
|
45 |
Supplement 1 |
p. 765-773
9 p.
|
artikel
|
| 25 |
EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary
|
Sant, Milena
|
|
2009
|
45 |
Supplement 1 |
p. 931-991
61 p.
|
artikel
|
| 26 |
Expert opinion in melanoma: The sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden
|
van Akkooi, Alexander C.J.
|
|
2009
|
45 |
Supplement 1 |
p. 2736-2742
7 p.
|
artikel
|
| 27 |
Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: Results from an integrated analysis
|
von Minckwitz, G.
|
|
2009
|
45 |
Supplement 1 |
p. 608-617
10 p.
|
artikel
|
| 28 |
Follow-up care after childhood cancer: Survivors’ expectations and preferences for care
|
Michel, G.
|
|
2009
|
45 |
Supplement 1 |
p. 1616-1623
8 p.
|
artikel
|
| 29 |
Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells
|
Lee, Tina X.
|
|
2009
|
45 |
Supplement 1 |
p. 1709-1720
12 p.
|
artikel
|
| 30 |
Health behaviours in older cancer survivors in the English Longitudinal Study of Ageing
|
Grimmett, Chloe
|
|
2009
|
45 |
Supplement 1 |
p. 2180-2186
7 p.
|
artikel
|
| 31 |
Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia
|
Hoogsteen, Ilse J.
|
|
2009
|
45 |
Supplement 1 |
p. 2906-2914
9 p.
|
artikel
|
| 32 |
Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells
|
Naldini, Antonella
|
|
2009
|
45 |
Supplement 1 |
p. 454-460
7 p.
|
artikel
|
| 33 |
Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma
|
Jee, Chang Do
|
|
2009
|
45 |
Supplement 1 |
p. 1282-1293
|
artikel
|
| 34 |
Improving the efficacy of cancer immunotherapy
|
Copier, J.
|
|
2009
|
45 |
Supplement 1 |
p. 1424-1431
8 p.
|
artikel
|
| 35 |
In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma
|
Pellizzari Tregno, Francesca
|
|
2009
|
45 |
Supplement 1 |
p. 2606-2617
12 p.
|
artikel
|
| 36 |
Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n =647) with primary breast cancer. A Danish Breast Cancer Cooperative Group Study
|
Willemoe, Gro L.
|
|
2009
|
45 |
Supplement 1 |
p. 2528-2536
9 p.
|
artikel
|
| 37 |
Lessons learned from independent central review
|
Ford, R.
|
|
2009
|
45 |
Supplement 1 |
p. 268-274
7 p.
|
artikel
|
| 38 |
Long-term survival expectations of cancer patients in Europe in 2000–2002
|
Brenner, Hermann
|
|
2009
|
45 |
Supplement 1 |
p. 1028-1041
14 p.
|
artikel
|
| 39 |
Lung cancer screening with low dose computed tomography: Where do we stand today?
|
van Klaveren, R.J.
|
|
2009
|
45 |
Supplement 1 |
p. 375-376
2 p.
|
artikel
|
| 40 |
Lung tumours with neuroendocrine differentiation
|
Travis, William D.
|
|
2009
|
45 |
Supplement 1 |
p. 251-266
16 p.
|
artikel
|
| 41 |
Managing cancer-related anaemia in congruence with the EORTC guidelines is an independent predictor of haemoglobin outcome: Initial evidence from the RESPOND study
|
Aapro, Matti
|
|
2009
|
45 |
Supplement 1 |
p. 8-11
4 p.
|
artikel
|
| 42 |
Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer
|
Parr, Christian
|
|
2009
|
45 |
Supplement 1 |
p. 1673-1683
11 p.
|
artikel
|
| 43 |
Minichromosome maintenance proteins in cancer screening
|
Coleman, Nicholas
|
|
2009
|
45 |
Supplement 1 |
p. 416-417
2 p.
|
artikel
|
| 44 |
Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014)
|
Matzinger, O.
|
|
2009
|
45 |
Supplement 1 |
p. 2782-2791
10 p.
|
artikel
|
| 45 |
Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours
|
Kalra, Ashish V.
|
|
2009
|
45 |
Supplement 1 |
p. 164-173
10 p.
|
artikel
|
| 46 |
Neuroblastoma in the newborn. A study of the Italian Neuroblastoma Registry
|
Gigliotti, Anna Rita
|
|
2009
|
45 |
Supplement 1 |
p. 3220-3227
8 p.
|
artikel
|
| 47 |
Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX
|
Shitara, Kohei
|
|
2009
|
45 |
Supplement 1 |
p. 1757-1763
7 p.
|
artikel
|
| 48 |
Obtaining ‘fresh’ consent for genetic research with biological samples archived 10 years ago
|
Vermeulen, Eric
|
|
2009
|
45 |
Supplement 1 |
p. 1168-1174
|
artikel
|
| 49 |
Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry
|
Garaventa, Alberto
|
|
2009
|
45 |
Supplement 1 |
p. 2835-2842
8 p.
|
artikel
|
| 50 |
Paclitaxel downregulates tissue factor in cancer and host tumour-associated cells
|
Napoleone, Emanuela
|
|
2009
|
45 |
Supplement 1 |
p. 470-477
8 p.
|
artikel
|
| 51 |
p53: Balancing tumour suppression and implications for the clinic
|
Buganim, Yosef
|
|
2009
|
45 |
Supplement 1 |
p. 217-234
18 p.
|
artikel
|
| 52 |
Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: A phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5)
|
Magnusson, Marie
|
|
2009
|
45 |
Supplement 1 |
p. 2488-2495
8 p.
|
artikel
|
| 53 |
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors
|
Skinner, Roderick
|
|
2009
|
45 |
Supplement 1 |
p. 3213-3219
7 p.
|
artikel
|
| 54 |
Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers
|
Soria, J.C.
|
|
2009
|
45 |
Supplement 1 |
p. 2333-2341
9 p.
|
artikel
|
| 55 |
Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours
|
Sessa, C.
|
|
2009
|
45 |
Supplement 1 |
p. 2116-2122
7 p.
|
artikel
|
| 56 |
Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer
|
Sessa, C.
|
|
2009
|
45 |
Supplement 1 |
p. 1153-1161
|
artikel
|
| 57 |
Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours
|
Kitzen, J.J.E.M.
|
|
2009
|
45 |
Supplement 1 |
p. 1764-1772
9 p.
|
artikel
|
| 58 |
Phase I/II study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer
|
Tamura, Kenji
|
|
2009
|
45 |
Supplement 1 |
p. 2132-2137
6 p.
|
artikel
|
| 59 |
Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma
|
Martín-Algarra, Salvador
|
|
2009
|
45 |
Supplement 1 |
p. 732-735
4 p.
|
artikel
|
| 60 |
Phase 3 randomised study of canfosfamide (Telcyta®, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer
|
Vergote, I.
|
|
2009
|
45 |
Supplement 1 |
p. 2324-2332
9 p.
|
artikel
|
| 61 |
Portrait of invasive lobular carcinoma of the breast
|
Pestalozzi, Bernhard C.
|
|
2009
|
45 |
Supplement 1 |
p. 450-451
2 p.
|
artikel
|
| 62 |
Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer
|
Das, Kakoli
|
|
2009
|
45 |
Supplement 1 |
p. 2239-2248
10 p.
|
artikel
|
| 63 |
Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters
|
Ebelt, Kathleen
|
|
2009
|
45 |
Supplement 1 |
p. 1664-1672
9 p.
|
artikel
|
| 64 |
Public funding of new cancer drugs: Is NICE getting nastier?
|
Mason, Anne R.
|
|
2009
|
45 |
Supplement 1 |
p. 1188-1192
|
artikel
|
| 65 |
Radiotherapy for locally advanced non-small cell lung cancer
|
Girard, Nicolas
|
|
2009
|
45 |
Supplement 1 |
p. 113-125
13 p.
|
artikel
|
| 66 |
Re-irradiation of brain tumours — evidence, indications and limitations
|
Short, S.C.
|
|
2009
|
45 |
Supplement 1 |
p. 410-411
2 p.
|
artikel
|
| 67 |
Resistance to EGF-R (erbB-1) and VEGF-R modulating agents
|
Dempke, Wolfram C.M.
|
|
2009
|
45 |
Supplement 1 |
p. 1117-1128
|
artikel
|
| 68 |
Safety and efficacy of a triple antiemetic combination with the NK-1 antagonist aprepitant in highly and moderately emetogenic multiple-day chemotherapy
|
Jordan, Karin
|
|
2009
|
45 |
Supplement 1 |
p. 1184-1187
|
artikel
|
| 69 |
Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaenia
|
Frakking, Florine N.J.
|
|
2009
|
45 |
Supplement 1 |
p. 505-512
8 p.
|
artikel
|
| 70 |
Screening of anti-glioma effects induced by sigma-1 receptor ligands: Potential new use for old anti-psychiatric medicines
|
Mégalizzi, Véronique
|
|
2009
|
45 |
Supplement 1 |
p. 2893-2905
13 p.
|
artikel
|
| 71 |
Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting
|
Dommett, R.
|
|
2009
|
45 |
Supplement 1 |
p. 2843-2849
7 p.
|
artikel
|
| 72 |
Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study
|
Scagliotti, Giorgio V.
|
|
2009
|
45 |
Supplement 1 |
p. 2298-2303
6 p.
|
artikel
|
| 73 |
Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium
|
Geoerger, Birgit
|
|
2009
|
45 |
Supplement 1 |
p. 2342-2351
10 p.
|
artikel
|
| 74 |
Targeting the WNT/β-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options
|
Gehrke, Iris
|
|
2009
|
45 |
Supplement 1 |
p. 2759-2767
9 p.
|
artikel
|
| 75 |
The cancer survival gap between elderly and middle-aged patients in Europe is widening
|
Quaglia, Alberto
|
|
2009
|
45 |
Supplement 1 |
p. 1006-1016
11 p.
|
artikel
|
| 76 |
The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status
|
Jover, Rodrigo
|
|
2009
|
45 |
Supplement 1 |
p. 365-373
9 p.
|
artikel
|
| 77 |
The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: The EORTC QLQ-BM22
|
Chow, Edward
|
|
2009
|
45 |
Supplement 1 |
p. 1146-1152
|
artikel
|
| 78 |
The FAMCARE-Patient scale: Measuring satisfaction with care of outpatients with advanced cancer
|
Lo, Christopher
|
|
2009
|
45 |
Supplement 1 |
p. 3182-3188
7 p.
|
artikel
|
| 79 |
The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer
|
Pinheiro, Céline
|
|
2009
|
45 |
Supplement 1 |
p. 2418-2424
7 p.
|
artikel
|
| 80 |
The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: Data from the randomised SBG 2000-1 study
|
Rosendahl, Mikkel
|
|
2009
|
45 |
Supplement 1 |
p. 3198-3204
7 p.
|
artikel
|
| 81 |
Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: A prospective observational safety study
|
Slobbe, Lennert
|
|
2009
|
45 |
Supplement 1 |
p. 2810-2817
8 p.
|
artikel
|
| 82 |
Tissue inhibitor metalloproteinase type-1 (TIMP-1), a novel cancer biomarker predicting response of adjuvant anthracycline-based chemotherapy in patients afflicted with primary breast cancer
|
Schmitt, Manfred
|
|
2009
|
45 |
Supplement 1 |
p. 2444-2446
3 p.
|
artikel
|
| 83 |
TNM: Therapeutically Not Mandatory
|
Epstein, Richard J.
|
|
2009
|
45 |
Supplement 1 |
p. 1111-1116
|
artikel
|
| 84 |
TRAIL-R1 polymorphisms and cancer susceptibility: An evidence-based meta-analysis
|
Chen, Bo
|
|
2009
|
45 |
Supplement 1 |
p. 2598-2605
8 p.
|
artikel
|
| 85 |
Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: Findings from the Anaemia Cancer Treatment (ACT) study
|
Ludwig, Heinz
|
|
2009
|
45 |
Supplement 1 |
p. 1603-1615
13 p.
|
artikel
|
| 86 |
Web-based resources for sun protection information – A French-language evaluation
|
Mahé, Emmanuel
|
|
2009
|
45 |
Supplement 1 |
p. 2160-2167
8 p.
|
artikel
|
| 87 |
Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1–3 brain metastases: Results of a matched pair analysis
|
Rades, Dirk
|
|
2009
|
45 |
Supplement 1 |
p. 400-404
5 p.
|
artikel
|
| 88 |
Wilms’ tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells
|
Glienke, Wolfgang
|
|
2009
|
45 |
Supplement 1 |
p. 874-880
7 p.
|
artikel
|
| 89 |
Wine, liquor, beer and risk of breast cancer in a large population
|
Li, Yan
|
|
2009
|
45 |
Supplement 1 |
p. 843-850
8 p.
|
artikel
|
Tijdschrift beschrijving